Categories
Change Password!
Reset Password!
EMA issues flu vaccine composition guidance for 20...
AGA releases best practice advice for managing exo...
The American Gastroenterological Association (AGA) has issued a new Clinical Practice Update offering vital guidance on the diagnosis and managem...
Study confirms modified bismuth quadruple therapy...
In the face of rising Helicobacter pylori (H. pylori) elimination failure, a new systematic review and meta-analysis offers promising evidence th...
Reddy’s and Henlius collaborate to commercialize d...
On 6 February 2025, Dr. Reddy’s Laboratories SA (Société Anonyme, a French term meaning "public limited company), a whol...
Remibrutinib impresses in chronic urticaria trial
In a major advancement for people living with chronic spontaneous urticaria (CSU), a new oral drug, remibrutinib, has proven substantial relief f...
Dr. Reddy’s and Bio-Thera forge strategic alliance...
As per the notification published on 26 March 2025, Dr. Reddy’s Laboratories Ltd., a global pharmaceutical leader based in India, has enter...
Sanofi and Dr. Reddy’s partner to introduce RSV pr...
On 28 April 2025, Dr. Reddy’s Laboratories Ltd. announced an exclusive distribution agreement with Sanofi Healthcare India Pvt. Ltd. for th...
New FDA-approved medication for hemophilia offers...
In a major advancement for hemophilia care on 28 March 2025, the Food and Drug Administration (FDA) has granted approval to fitusiran (small inte...
Efficacy of abdominal breathing exercise for GERD
This randomized controlled study aimed to evaluate the impact of strengthening the crura of the diaphragm—a component of the lower oesophag...
Iron Deficiency Anemia as a Trigger for Restless L...
Cystic Duct Perforation: A Potential Complication...
Therapeutic potential of saroglitazar in dyslipide...
This systematic review and meta-analysis explored the effectiveness and safety profile of saroglitazar (antidiabetic medication) in patients suff...
Comparison of oxymetazoline, tranexamic acid, and...
This study sought to explore the effectiveness of locally administered oxymetazoline, tranexamic acid, and an epinephrine–lidocaine combina...
Comparative analysis of sphingosine-1-phosphate re...
Sphingosine-1-phosphate receptor modulators (S1PRMs) are widely utilized for treating relapsing multiple sclerosis (MS), with each agent illustra...
Renal function–dependent effects of ferric derisom...
In patients with heart failure (HF) and iron deficiency (ID), the benefit of intravenous iron may differ depending on kidney function.
Survey reveals knowledge gaps in obesity and baria...
P-CABs emerge as promising therapy for acid-relate...
A comprehensive literature review of recent clinical trials suggests that potassium-competitive acid blockers (P-CABs) could offer faster and equ...
Continuing metformin in early pregnancy may improv...
A systematic review and meta-analysis suggests that women with polycystic ovary syndrome (PCOS) who continue metformin from preconception through...
Bidirectional genetic link found between depressio...
Depression increases the risk of myalgia, fibromyalgia, and osteoarthritis, while osteoarthritis in turn raises the risk of depression, indicatin...
Metformin vs. acupuncture: Which works better for...
Metformin is more effective than acupuncture in improving insulin resistance in women with polycystic ovary syndrome (PCOS), while acupuncture&md...
Study compares SGLT2 inhibitors vs. semaglutide in...
In accordance with the findings of a retrospective observational study, both sodium-glucose cotransporter-2 (SGLT2) inhibitors and the glucagon-l...
Rimegepant shows superior patient persistence over...
In a retrospective cohort analysis of US insurance claims data, migraine patients initiating treatment with rimegepant demonstrate substantially...
Experts urge sustained, individualized strategies...
A narrative review, based on a broad literature search in PubMed, synthesized best-practice recommendations for diagnosing and treating obesity i...
Early rimegepant use relieves fasting-triggered he...
A randomized open-label trial has demonstrated that rimegepant, a calcitonin gene-related peptide (CGRP) receptor antagonist, may offer effective...
Apixaban matches enoxaparin in preventing blood cl...
A new research suggests that apixaban, a direct-acting oral anticoagulant (DOAC), could serve as a safe and effective substitute to enoxaparin fo...
